Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer

Joo Mi Yi, Mashaal Dhir, Leander Van Neste, Stephanie R. Downing, Jana Jeschke, Sabine C. Gloeckner, Marilia de Freitas Calmon, Craig M. Hooker, Juan M. Funes, Chris Boshoff, Kim M. Smits, Manon van Engeland, Matty P. Weijenberg, Christine A. Iacobuzio-Donahue, James G. Herman, Kornel E. Schuebel, Stephen B. Baylin, Nita Ahuja

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1535-1545
JournalClinical Cancer Research
Volume17
Issue number6
DOIs
Publication statusPublished - 15 Mar 2011

Cite this

Yi, J. M., Dhir, M., Van Neste, L., Downing, S. R., Jeschke, J., Gloeckner, S. C., Calmon, M. D. F., Hooker, C. M., Funes, J. M., Boshoff, C., Smits, K. M., van Engeland, M., Weijenberg, M. P., Iacobuzio-Donahue, C. A., Herman, J. G., Schuebel, K. E., Baylin, S. B., & Ahuja, N. (2011). Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer. Clinical Cancer Research, 17(6), 1535-1545. https://doi.org/10.1158/1078-0432.CCR-10-2509